株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

上腕骨外側上顆炎(テニス肘):パイプライン製品の分析

Lateral Epicondylitis(Tennis Elbow) - Pipeline Review, H1 2015

発行 Global Markets Direct 商品コード 302495
出版日 ページ情報 英文 39 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
上腕骨外側上顆炎(テニス肘):パイプライン製品の分析 Lateral Epicondylitis(Tennis Elbow) - Pipeline Review, H1 2015
出版日: 2015年03月19日 ページ情報: 英文 39 Pages
概要

上腕骨外側上顆炎(テニス肘)は、腱炎の一種で、肘と腕の痛みを引き起こします。老齢化、テニスやスカッシュ、ウエイトリフティングといったスポーツがこの疾患を患う主要因として挙げられます。

当レポートでは、上腕骨外側上顆炎(テニス肘)治療薬の開発状況について調査しており、パイプライン製品の概要、治験の段階別の製品概要、主要企業のプロファイル、薬剤のプロファイル、パイプライン製品の最新動向などを提供しています。

イントロダクション

  • 調査範囲

上腕骨外側上顆炎(テニス肘)の概要

治療薬の開発

  • パイプライン製品の概要
  • パイプライン製品の比較分析

上腕骨外側上顆炎(テニス肘):企業で開発中の治療薬

上腕骨外側上顆炎(テニス肘):パイプライン製品の概況

  • 後期段階の製品
  • 臨床段階の製品

上腕骨外側上顆炎(テニス肘):企業で開発中の製品

上腕骨外側上顆炎(テニス肘)の治療薬開発に従事している企業

  • 生化学工業
  • Chugai Pharmaceutical Co., Ltd.
  • Teikoku Pharma USA, Inc.
  • Molecular Pharmacology (USA) Limited
  • Kasiak Research Pvt. Ltd.

上腕骨外側上顆炎(テニス肘):治療薬の評価

  • 単剤製品
  • 標的別
  • 作用機序別
  • 投与経路別
  • 分子タイプ別

薬剤プロファイル

  • ヒアルロン酸ナトリウム
  • TPW-182
  • Refaheal
  • RCT-01
  • MPLTL-100

上腕骨外側上顆炎(テニス肘):最近のパイプライン動向

上腕骨外側上顆炎(テニス肘):休止中のプロジェクト

上腕骨外側上顆炎(テニス肘):製品開発のマイルストーン

  • 主なニュースとプレスリリース

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC6445IDB

Summary

Global Markets Direct's, 'Lateral Epicondylitis(Tennis Elbow) - Pipeline Review, H1 2015', provides an overview of the Lateral Epicondylitis(Tennis Elbow)'s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Lateral Epicondylitis(Tennis Elbow), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lateral Epicondylitis(Tennis Elbow) and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Lateral Epicondylitis(Tennis Elbow)
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Lateral Epicondylitis(Tennis Elbow) and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Lateral Epicondylitis(Tennis Elbow) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Lateral Epicondylitis(Tennis Elbow) pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Lateral Epicondylitis(Tennis Elbow)
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Lateral Epicondylitis(Tennis Elbow) pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
    • Lateral Epicondylitis(Tennis Elbow) Overview
  • Therapeutics Development
    • Pipeline Products for Lateral Epicondylitis(Tennis Elbow) - Overview
    • Pipeline Products for Lateral Epicondylitis(Tennis Elbow) - Comparative Analysis
  • Lateral Epicondylitis(Tennis Elbow) - Therapeutics under Development by Companies
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline Products Glance
    • Late Stage Products
    • Clinical Stage Products
  • Lateral Epicondylitis(Tennis Elbow) - Products under Development by Companies
  • Lateral Epicondylitis(Tennis Elbow) - Companies Involved in Therapeutics Development
    • Kasiak Research Pvt. Ltd.
    • Molecular Pharmacology (USA) Limited
    • RepliCel Life Sciences, Inc.
    • Seikagaku Corporation
    • Teikoku Pharma USA, Inc.
  • Lateral Epicondylitis(Tennis Elbow) - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Drug Profiles
    • ALLO-ASC - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hyaluronate sodium - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MPLTL-100 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RCT-01 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Refaheal - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPW-182 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Lateral Epicondylitis (Tennis Elbow) - Recent Pipeline Updates
  • Lateral Epicondylitis(Tennis Elbow) - Dormant Projects
  • Lateral Epicondylitis(Tennis Elbow) - Discontinued Products
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow), H1 2015
  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow) - Comparative Analysis, H1 2015
  • Number of Products under Development by Companies, H1 2015
  • Comparative Analysis by Late Stage Development, H1 2015
  • Comparative Analysis by Clinical Stage Development, H1 2015
  • Products under Development by Companies, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Kasiak Research Pvt. Ltd., H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Molecular Pharmacology (USA) Limited, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by RepliCel Life Sciences, Inc., H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Seikagaku Corporation, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Pipeline by Teikoku Pharma USA, Inc., H1 2015
  • Assessment by Monotherapy Products, H1 2015
  • Number of Products by Stage and Target, H1 2015
  • Number of Products by Stage and Mechanism of Action, H1 2015
  • Number of Products by Stage and Route of Administration, H1 2015
  • Number of Products by Stage and Molecule Type, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) Therapeutics - Recent Pipeline Updates, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Dormant Projects, H1 2015
  • Lateral Epicondylitis(Tennis Elbow) - Discontinued Products, H1 2015

List of Figures

  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow), H1 2015
  • Number of Products under Development for Lateral Epicondylitis(Tennis Elbow) - Comparative Analysis, H1 2015
  • Number of Products under Development by Companies, H1 2015
  • Comparative Analysis by Clinical Stage Development, H1 2015
  • Assessment by Monotherapy Products, H1 2015
  • Number of Products by Top 10 Targets, H1 2015
  • Number of Products by Stage and Top 10 Targets, H1 2015
  • Number of Products by Top 10 Mechanism of Actions, H1 2015
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
  • Number of Products by Top 10 Routes of Administration, H1 2015
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2015
  • Number of Products by Top 10 Molecule Types, H1 2015
  • Number of Products by Stage and Top 10 Molecule Types, H1 2015
Back to Top